Region: United States
Category: Osteoporosis
Category: Osteoporosis
United States Osteoporosis
(2 reports matching your criteria)
-
United States Women’s Health Market By Drug (ACTONEL, YAZ, Yasmin, Yasminelle, FORTEO, Minastrin 24 Fe, Mirena, NuvaRing, ORTHO TRI-CY LO, Premarin, Prolia, Reclast/Aclasta, XGEVA, Zometa, Others), By Application (Hormonal Infertility, Contraceptives, Postmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Menopause, Polycystic Ovary Syndrome), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Region and Competition, Opportunity, and Forecast, 2019-2029F
... Uterine Fibroids, Menopause, Polycystic Ovary Syndrome), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Region and Competition, Opportunity, and Forecast, 2019-2029F United States Women’s Health Market was valued at USD 19.78 billion in 2023 ... Read More
-
North America Osteoporosis Treatment Market, By Drug Class (Bisphosphonate, Hormone Replacement Therapy, Selective Estrogen Receptor Modulator, Rank Ligand Inhibitor and Others), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others), By Country (U.S. and Canada), Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... Pharmacies and Others), By Country (U.S. and Canada), Trend Analysis, Competitive Market Share & Forecast, 2018-2028 North America Osteoporosis Treatment Market to Cross USD 10.25 Billion by 2028 North America Osteoporosis Treatment Market is growing ... Read More
Research Assistance
